High-tech in interstitial lung diseases: just hype and gadgets?

Hot topic
Chairs: M. Wijsenbeek (Rotterdam, Netherlands), M. Kreuter (Heidelberg, Germany)
Aims: to explain novel techniques and their role in the diagnosis and treatment follow-up of interstitial lung diseases (ILDs); to explain the additive value of optical coherence tomography in the diagnosis of ILDs; to discuss genetic testing of ILDs and if it has any role in daily practice; to explain what artificial intelligence can bring to the field of ILDs; to discuss the pros and cons of e-health and biomarkers in daily practice and research of ILDs.

New endoscopic techniques to diagnose interstitial lung diseases V. Poletti (Forlì, Italy)
It's all in our genes M. Molina Molina (Barcelona, Spain)
Artificial intelligence meets interstitial lung diseases S. Walsh (London, United Kingdom)
How to better assess and predict disease progression and treatment response: home-based spirometry, biomarkers or …? T. Maher (St. Albans, United Kingdom)